figures are annualized, even a gap of 1.00% can be huge over time. RS Emerging Growth RSEGX vs. Putnam OTC Emerging Growth POEGX Jim Callinan left Putnam for RS in the summer of 1996. Back then Putnam was talking about how their success was all about teams
Harbor Bond than Dreyfus A Bonds Plus, and you could have done much worse than the Dreyfus Fund. Trade Putnam OTC Emerging Growth A POEGX for Heritage Mid Cap Stock A HMCAX. I've been really pleased by the changes at Putnam, but Rome wasn
appear that Putnam's process and teams were pretty lousy. From July 1996 through September 2006, Putnam OTC Emerging Growth POEGX is 27% in the red compared with a gain of 151% for the RS fund. That figure for RS looks better than it is, though. Both
instance, have toned things down. Similarly, Putnam has been clobbered by the awful showings of Putnam OTC Emerging Growth POEGX and others. With manager changes and newer risk controls in place, it's unlikely that we'll see such extreme performance
Securities NREBX. And Putnam Convertible Income-Growth PCONX, Putnam Tax-Free High Yield PTHAX, and Putnam OTC Emerging Growth POEGX have posted awful returns over time while frequently changing managers and occasionally adjusting their disciplines. A handful
shareholders will want to see signs that things are turning around here before sending new money. Putnam OTC Emerging Growth POEGX Okay, this one might fall into the easy-target category. After soaring along with many of its speculative holdings in the
FKACX 56.49% Percentile rank: 89 Fidelity Aggressive Growth FDEGX 63.99% Percentile rank: 96 Putnam OTC Emerging Growth POEGX 67.66% Percentile rank: 99 Ugly, isn t it? All of these shops refrained from launching Internet-specific funds in 1998
Vanguard U.S. Growth VWUSX, which recently changed managers. Another 20% of you picked Chip Morris's T. Rowe Price Science & Tech PRSCX fund, while 17% picked Janus Venture JAVTX, and only 9% chose Putnam OTC Emerging Growth POEGX .
focused on the long term. However, one of my three candidates was just a bad idea: I mentioned Putnam OTC Emerging Growth POEGX because it had been clocked in 2000, yet still had all the great resources of Putnam to draw upon. My mistake was betting
lukewarm on: Merck MRK, DST Systems DST, and Bausch & Lomb BOL. Funds We Have Concerns About Putnam OTC Emerging Growth POEGX , by Kelli Stebel " its abysmal performance isn't the only reason shareholders should consider cutting the ties." First